| Dear Reader, You have two days left to become a Mauldin Economics VIP. At midnight tomorrow, on March 17, new-member enrollment will close again for another six months. We’ve just witnessed the market go from an all-time high into bear market territory in record time. Is it time to panic? No! As John Mauldin likes to point out, we’ve all made it through worse crises in our lives. And we’ll make it through this one too. While we can’t assist on the physical-health front, we’ve got you covered when it comes to your financial health. Our analysts are on high alert to help you protect your portfolio and find profits at the same time. A choppy market, and even one in freefall, can bring tremendous buying opportunities. When you become a VIP today, you will have our best research at your disposal... week after week, month after month: Street Freak (value $1,795)
Contrarian choices for the best risk-adjusted returns, brought to you by former Lehman Brothers trader and renowned analyst Jared Dillian. In a falling market, these can be true gold.
ETF 20/20 (value $99)
The right ETFs can make for steady-growth, solid investments—a must-have in a volatile environment.
In the Money (value $1,995)
Headed up by Robert Ross, In the Money can help you generate outsized returns using stocks and low-risk options strategies... and provides portfolio insurance in periods of high volatility.
Yield Shark (value $199)
When the stock market experiences wild swings, investing in large-cap, low-vol dividend payers and funds is a good strategy. Learn how to spot the big trends Robert Ross uses to lower your portfolio’s risk exposure.
Biotech Millionaire (value $2,495)
Thanks to coronavirus, some biotechs that work on vaccines have skyrocketed. You’ll want this premium alert service with big upside in your list of publications. With the help of the unique C.A.S.H. system, Chris Wood and Jake Weber bring you the best, most profitable stocks for exceptional short- to mid-term gains.
Healthy Returns (value $119)
When large to mid-size healthcare companies are moving through a successful slew of clinical trials, even a market correction can’t stop them. Right now, Chris Wood has several winners like this in his Healthy Returns portfolio... one of them just handed subscribers a “free ride.”
Over My Shoulder (value $179)
Whether it’s coronavirus or other high-interest events—the expert analysis and insights from the world’s top economists and money managers is a must-read. Carefully curated by John Mauldin and Patrick Watson, this service gives you the most pertinent information, much of it client-only reports or articles that regular investors normally wouldn’t get to see. Plus... VIP Week in Review: You’ll never miss a trade again with this weekly summary, delivered every Friday. Combined, all these services are worth $6,881. But all you’ll pay as a VIP is $2,495 for a one-year bundle subscription. It gets even less when you sign up for a two-year subscription. In total, you can save up to 75% as a card-carrying VIP. Please don’t hesitate to take us up on this offer. If you’re not satisfied for whatever reason, you’ll have 30 days to cancel your subscription for a full refund. And if you stay with us, your low-cost membership fee will be locked in forever, even if we raise the price of this service in the future. Please seize this opportunity now before the offer ends tomorrow. Sincerely, Ed D’Agostino
Publisher, Mauldin Economics |
